Clear cell renal cell carcinoma (ccRCC) is characterized by its aggressive behavior and complex molecular heterogeneity, posing significant challenges for treatment and prognostication. This study offers a comprehensive analysis of ccRCC by leveraging both bulk and single‐cell RNA sequencing data, with a specific aim to unravel the complexities of sphingolipid metabolism and the intricate dynamics within the tumor microenvironment (TME). By examining ccRCC samples sourced from public databases, our investigation delves deep into the genetic and transcriptomic landscape of this cancer type. Employing advanced analytical techniques, we have identified pivotal patterns in gene expression and cellular heterogeneity, with a special focus on the roles and interactions of various immune cells within the TME. Significantly, our research has unearthed insights into the dynamics of sphingolipid metabolism in ccRCC, shedding light on its potential implications for tumor progression and strategies for immune evasion. A novel aspect of this study is the development of a risk score model designed to enhance prognostic predictions for ccRCC patients, which is currently pending external validation to ascertain its clinical utility. Despite its contributions, the study is mindful of its limitations, including a reliance on observational data from public sources and a primary focus on RNA sequencing data, which may constrain the depth and generalizability of the findings. The study does not encompass critical aspects, such as protein expression, posttranslational modifications, and comprehensive metabolic profiles. Moreover, its retrospective design underscores the necessity for future prospective studies to solidify these preliminary conclusions. Our findings illuminate the intricate interplay between genetic alterations, sphingolipid metabolism, and immune responses in ccRCC. This research not only enhances our understanding of the molecular foundations of ccRCC but also paves the way for the development of targeted therapies and personalized treatment modalities. The study underlines the importance of cautious interpretation of results and champions ongoing research using diverse methodologies to thoroughly comprehend and effectively combat this formidable cancer type.

中文翻译：

---

大量和单细胞 RNA 测序的综合分析揭示了透明细胞肾细胞癌的鞘脂代谢和免疫景观


透明细胞肾细胞癌 （ccRCC） 的特点是其侵袭性行为和复杂的分子异质性，对治疗和预后提出了重大挑战。本研究通过利用大量和单细胞 RNA 测序数据对 ccRCC 进行了全面分析，具体目的是揭示鞘脂代谢的复杂性和肿瘤微环境 （TME） 中错综复杂的动力学。通过检查来自公共数据库的 ccRCC 样本，我们的调查深入研究了这种癌症类型的遗传和转录组学景观。采用先进的分析技术，我们确定了基因表达和细胞异质性的关键模式，特别关注 TME 中各种免疫细胞的作用和相互作用。值得注意的是，我们的研究揭示了 ccRCC 中鞘脂代谢动力学的见解，阐明了其对肿瘤进展的潜在影响和免疫逃避策略。本研究的一个新方面是开发了一种风险评分模型，旨在增强 ccRCC 患者的预后预测，该模型目前正在等待外部验证以确定其临床效用。尽管做出了贡献，但该研究也注意到了其局限性，包括依赖来自公共来源的观察数据以及主要关注 RNA 测序数据，这可能会限制研究结果的深度和普遍性。该研究不包括关键方面，例如蛋白质表达、翻译后修饰和综合代谢特征。此外，它的回顾性设计强调了未来前瞻性研究巩固这些初步结论的必要性。 我们的研究结果阐明了 ccRCC 中遗传改变、鞘脂代谢和免疫反应之间错综复杂的相互作用。这项研究不仅增强了我们对 ccRCC 分子基础的理解，还为靶向治疗和个性化治疗方式的发展铺平了道路。该研究强调了谨慎解释结果的重要性，并支持使用各种方法进行正在进行的研究，以彻底理解和有效对抗这种可怕的癌症类型。